Risk & Capital Management
Next Week Could Be Key for Atlantic Hurricane Season
The Atlantic hurricane season is about to enter its most active phase as conditions for the powerful storms improve across the basin. Wind shear that can tear budding storms apart has been ...
U.S. Regulator Wants Auditors to Add Commentary, Not Analysis
Auditors know a lot about what lurks between the extremes of "pass" or "fail" - the only grades they are now permitted to assign to corporate financial statements - and the U.S. board that oversees ...
Goldman Sachs to Sell Its European Insurance Business
Goldman Sachs Group Inc. said it probably will sell a majority stake in its European insurance business in the next 12 months. The business, known as Rothesay Life Ltd. and run by Addy Loudiadis, had ...
Why Greed Isn’t Good
Imagine yourself betting on the long- term survival of two types of people. One is the classic egoist, focused and ruthless. The other is more selfless, willing to help fellow humans without any ...
Berkshire Beats Bond Rout, Other Insurers By Avoiding Bonds
Warren Buffett's preference for buying stocks and whole companies rather than bonds is helping Berkshire Hathaway Inc. weather a spike in interest rates better than other insurers. Book value rose 2 ...
P/C Insurers Face Challenges If Terrorism Risk Insurance Is Not Renewed: Fitch
If Congress fails to renew or makes significant changes to the federal government's terrorism risk insurance program, some insurers will be forced to significantly alter their underwriting portfolios ...
Allstate Reports Disaster Costs Down, Investments Up for Q2
Allstate Corp., the largest publicly traded U.S. auto and home insurer, said second quarter profit climbed on investment gains and reduced costs tied to natural disasters. Net income climbed 2.6 ...
Corporate Risk Consultants Uneasy After China’s Detention of Investigators
The detention by Chinese authorities of a British corporate investigator and his American wife in the wake of a corruption probe into pharmaceutical giant GlaxoSmithKline has had a chilling effect on ...